Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

News Daily News

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

Michael O'Riordan

August 18, 2022

News Industry News

IMPRESSION Randomized Trial: Past the halfway mark and progressing rapidly

January 22, 2022

News Daily News

Longer Patency, Fewer Repeat Procedures With Paclitaxel DCBs in Dialysis Patients

L.A. McKeown

August 21, 2020

Presentation TCT Abstracts Posters 2018

Impact of HDL to major adverse limb event in end-stage renal disease on hemodialysis due to diabetic nephropathy. from PREDICT study

Presenter: Tamon Kato

September 25, 2018

News Industry News

Medtronic Enrolls First Patient in Study of IN.PACT(TM) AV Access Drug-Coated Balloon in Patients with End-Stage Renal Disease

May 25, 2017

News Industry News

Medtronic Receives IDE Approval to Initiate Study of IN.PACT® Admiral® Drug-Coated Balloon for a New Indication in Patients with End-Stage Renal Disease

January 30, 2017

News Industry News

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

August 14, 2015

News Daily News

Role of Anticoagulation Explored in Patients With A-Fib, Renal Disease

Yael L. Maxwell

December 10, 2014

News Daily News

Bioengineered Vessels Appear Safe for Use in Dialysis Patients

November 21, 2013

News Daily News

Ischemic Preconditioning Limits Contrast-Induced Kidney Damage

Caitlin E. Cox

July 02, 2012

Presentation TCT 2012

Objectives: The purpose of this study was to determine the functional impact of cilostazol in patients with chronic kidney disease (CKD) undergoing hemodialysis.

Presenter: Weon Kim, Won-Yu Kang, Jong-Shin Woo

January 03, 2012

Advertisement

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

IMPRESSION Randomized Trial: Past the halfway mark and progressing rapidly

Longer Patency, Fewer Repeat Procedures With Paclitaxel DCBs in Dialysis Patients

Impact of HDL to major adverse limb event in end-stage renal disease on hemodialysis due to diabetic nephropathy. from PREDICT study

Medtronic Enrolls First Patient in Study of IN.PACT(TM) AV Access Drug-Coated Balloon in Patients with End-Stage Renal Disease

Medtronic Receives IDE Approval to Initiate Study of IN.PACT® Admiral® Drug-Coated Balloon for a New Indication in Patients with End-Stage Renal Disease

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

Role of Anticoagulation Explored in Patients With A-Fib, Renal Disease

Bioengineered Vessels Appear Safe for Use in Dialysis Patients

Ischemic Preconditioning Limits Contrast-Induced Kidney Damage

Objectives: The purpose of this study was to determine the functional impact of cilostazol in patients with chronic kidney disease (CKD) undergoing hemodialysis.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content